XML 14 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation - Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Stock-Based Compensation        
Available for grant (in shares) 350,191   350,191  
Share-based compensation costs recognized $ 776 $ 890 $ 2,488 $ 2,949
Weighted-average grant-date fair value     2,453  
Remaining unamortized expense 3,359   $ 3,359  
Remaining unamortized expense period     1 year 4 months 24 days  
Options        
Stock-Based Compensation        
Number of options granted (in shares)     361,800  
Share-based compensation costs recognized 758 917 $ 2,427 2,777
Options | BioXcel Corporation        
Stock-Based Compensation        
Share-based compensation costs recognized $ 18 $ 61 $ (27) $ 172